AMC
AMC Entertainment Holdings, Inc.
AMC has the edge over BODI overall, supported by stronger fundamentals and lower modeled downside.
BODI
The Beachbody Company, Inc.
BODI trails on the overall score without a compensating advantage in the available component scores.
AMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Under pressure |
AMC's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is under pressure.
BODI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Under pressure | |
| Strong |
BODI's profitability and balance sheet are currently healthy, but its revenue and cash flow are under pressure.
AMC PE Valuation
AMC has no meaningful PE right now: it lost money over the past year.
BODI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 2.1x | $3.25 | — |
| Cheap | 2.6x | $4.11 | +27% |
| Fair | 4.1x | $6.41 | +97% |
| Expensive | 15x | $22.97 | +607% |
Historical ranges are pointers, not guarantees.
BODI's PE is 2.1x, but its earnings don't support one, so it isn't a reliable read right now.
AMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
AMC has the edge over BODI on the outlook, with more favorable revenue expectations.
BODI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| Improving | |
| Limited | |
| Low |
Analysts expect BODI's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
AMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.40 | +$0.94 |
| Q2 2026 | -$1.10 | -$0.28 |
| Q1 2026 | -$1.09 | -$0.18 |
| Q4 2025 | -$1.34 | -$0.28 |
| Q3 2025 | -$1.34 | +$0.29 |
| Q2 2025 | -$0.82 | +$0.67 |
| Q1 2025 | -$0.91 | +$0.38 |
| Q4 2024 | -$1.06 | +$1.31 |
AMC lost $0.40 per share over the past year, a smaller loss than the year before.
BODI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.56 | +$7.81 |
| Q2 2026 | $1.69 | +$10.20 |
| Q1 2026 | $0.73 | +$9.98 |
| Q4 2025 | -$0.41 | +$10.10 |
| Q3 2025 | -$6.25 | +$9.66 |
| Q2 2025 | -$8.51 | +$11.15 |
| Q1 2025 | -$9.25 | +$12.82 |
| Q4 2024 | -$10.51 | +$13.96 |
BODI has the edge over AMC on earnings quality, reporting a profit while its opponent remains loss making.
AMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +32% |
| Q2 2026 | $1.6B | +14% |
| Q1 2026 | $1B | +21% |
| Q4 2025 | $1.3B | -1.4% |
| Q3 2025 | $1.3B | -3.6% |
| Q2 2025 | $1.4B | +36% |
| Q1 2025 | $862.5M | -9.3% |
| Q4 2024 | $1.3B | +18% |
AMC has the edge over BODI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +12 points |
| Q2 2026 | 15% | +8.3 points |
| Q1 2026 | -4.4% | +13 points |
| Q4 2025 | 0% | -0.3 points |
| Q3 2025 | 2.8% | -2.6 points |
| Q2 2025 | 6.6% | +11 points |
| Q1 2025 | -17% | -5.5 points |
| Q4 2024 | 0.4% | +14 points |
AMC has the edge over BODI on profitability, with a higher operating margin.
BODI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $45.2M | -25% |
| Q2 2026 | $49.6M | -22% |
| Q1 2026 | $54.3M | -25% |
| Q4 2025 | $55.5M | -36% |
| Q3 2025 | $59.9M | -41% |
| Q2 2025 | $63.9M | -42% |
| Q1 2025 | $72.4M | -40% |
| Q4 2024 | $86.4M | -27% |
BODI's revenue has slid since its 2020 peak: $45M last quarter, down 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -5.4 points |
| Q2 2026 | 3.4% | +9.6 points |
| Q1 2026 | 5.7% | +11 points |
| Q4 2025 | 15% | +53 points |
| Q3 2025 | 8.3% | +21 points |
| Q2 2025 | -6.2% | +2.4 points |
| Q1 2025 | -5.1% | +3.9 points |
| Q4 2024 | -38% | +13 points |
BODI's operating margin was 2.9% last quarter, down 5.4 points from the same quarter a year ago.
AMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $109.3M | +$190.4M |
| Q2 2026 | $190.1M | +114% |
| Q1 2026 | -$174.7M | +$242.3M |
| Q4 2025 | $43.3M | -62% |
| Q3 2025 | -$81.1M | +$11.1M |
| Q2 2025 | $88.9M | +$168.1M |
| Q1 2025 | -$417M | -$178.2M |
| Q4 2024 | $113.9M | +$263.8M |
AMC has the edge over BODI on cash generation, producing positive trailing cash flow while its opponent burns cash.
BODI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.4M | -171% |
| Q2 2026 | -$4M | -265% |
| Q1 2026 | -$1.7M | -205% |
| Q4 2025 | $4.3M | +$11.6M |
| Q3 2025 | $9M | +16881% |
| Q2 2025 | $2.4M | +$4.6M |
| Q1 2025 | $1.6M | -78% |
| Q4 2024 | -$7.3M | +$1.7M |
BODI has burned cash in most quarters: −$8M over the past year, against $6M the year before.
AMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +24% | +175M shares |
| 1 year | +107% | +463M shares |
| 3 years | +767% | +793M shares |
| 5 years | +4063% | +875M shares |
AMC has 897M diluted shares, up 107% from a year ago.
BODI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -6.2% | -487K shares |
| 1 year | +5.3% | +372K shares |
| 3 years | +20% | +1.2M shares |
| 5 years | +22% | +1.3M shares |
BODI has the edge over AMC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
AMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 9.2x | High |
| Q4 2025 | 12.2x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 10.7x | High |
| Q1 2025 | 18.6x | High |
| Q4 2024 | 14.3x | High |
AMC's net debt is about 4.0 years of its operating earnings (EBITDA), down from 12 years a year ago.
BODI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2020 | -1.0x | Net Cash |
BODI has the edge over AMC on leverage, with a lower net debt burden relative to earnings.
AMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.3 | Neutral |
| Stochastic | 65.4 | Neutral |
AMC's weekly RSI is 67 (neutral) and its Stochastic is 65 (neutral).
BODI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.4 | Oversold |
| Stochastic | 2.2 | Oversold |
BODI's weekly RSI is 29 (oversold) and its Stochastic is 2 (oversold).
AMC PE vs Communication Services Sector
AMC has no meaningful PE right now: it lost money over the past year.
BODI PE vs Communication Services Sector
| Metric | BODI | Sector median | Relative |
|---|---|---|---|
| PE | 2.1x | 16x | 87% below |
| PE % | 0 | 28 | 28 pts below |
BODI is trading at 2.1x earnings, a 87% discount to the Communication Services sector's median of 16x, though its earnings don't support one.
AMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.01 | 11% above |
| 20 week MA | $2.64 | 27% above |
| 50 week MA | $2.01 | 66% above |
| 100 week MA | $2.53 | 32% above |
| 200 week MA | $10.9 | 69% below |
AMC has the edge over BODI on trend strength, trading above more of its moving averages.
BODI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.31 | 25% below |
| 20 week MA | $6.65 | 51% below |
| 50 week MA | $9.06 | 64% below |
| 100 week MA | $7.32 | 56% below |
| 200 week MA | $10.8 | 70% below |
BODI is in a downtrend: it's below all five of its weekly moving averages, and 70% below its 200-week average.
AMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $12.6 | -66% |
| 2021 | $12.6 | $142.6 | +1036% |
| 2022 | $142.6 | $44.0 | -69% |
| 2023 | $44.0 | $6.12 | -86% |
| 2024 | $6.12 | $4.00 | -35% |
| 2025 | $4.00 | $1.69 | -58% |
| 2026 YTD | $1.69 | $3.34 | +98% |
AMC has the edge over BODI on returns for 2026, with the stronger performance.
BODI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $523.5 | $126.0 | -76% |
| 2022 | $126.0 | $27.3 | -78% |
| 2023 | $27.3 | $8.29 | -70% |
| 2024 | $8.29 | $6.07 | -27% |
| 2025 | $6.07 | $10.1 | +66% |
| 2026 YTD | $10.1 | $3.25 | -68% |
BODI has finished lower in four of the last five years. It's down 68% so far in 2026.